LAURA HIGGINBOTHAM: Open Payments
NPI 1659630069 · LEANDER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,156 in 54 payments from 18 companies in 2025. Trend: 2023 $962 · 2024 $1,345 · 2025 $1,156
Food & beverage: $1,156
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $195 |
| Novo Nordisk Inc | 8 | $160 |
| ABBVIE INC. | 10 | $139 |
| Amgen Inc. | 8 | $135 |
| Lundbeck LLC | 4 | $95 |
| PFIZER INC. | 5 | $88 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $32 |
Products named: FARXIGA, VYEPTI, OTEZLA, QULIPTA, Ozempic, JARDIANCE, Auvelity, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
